A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.

<h4>Objective</h4>We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the prog...

Full description

Saved in:
Bibliographic Details
Main Authors: Boyd C P Ghosh, Roger H S Carpenter, James B Rowe
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0074486&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849722204420308992
author Boyd C P Ghosh
Roger H S Carpenter
James B Rowe
author_facet Boyd C P Ghosh
Roger H S Carpenter
James B Rowe
author_sort Boyd C P Ghosh
collection DOAJ
description <h4>Objective</h4>We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the progression of pathophysiology.<h4>Methods</h4>Twenty three patients with progressive supranuclear palsy (Richardson's syndrome) were compared to 22 matched controls at baseline and 16 of these patients compared at baseline and one year using: the progressive supranuclear palsy rating scale; the unified Parkinson's disease rating scale; the revised Addenbrooke's cognitive examination; the frontal assessment battery; the cubes section of the visual object and space perception battery; the Hayling and Brixton executive tests; and saccadic latencies.<h4>Results</h4>Patients were significantly impaired in all domains at baseline. However, cognitive performance was maintained over a year on the majority of tests. The unified Parkinson's disease rating scale, saccadic latency and progressive supranuclear palsy rating scale deteriorated over a year, with the latter showing the largest change. Power estimates indicate that using the progressive supranuclear palsy rating scale as an outcome measure in a clinical trial would require 45 patients per arm, to identify a 50% reduction in rate of decline with 80% power.<h4>Conclusions</h4>Motor, oculomotor and cognitive domains deteriorate at different rates in progressive supranuclear palsy. This may be due to differential degeneration of their respective cortical-subcortical circuits, and has major implications for the selection of outcome measures in clinical trials due to wide variation in sensitivity to annual rates of decline.
format Article
id doaj-art-d72e23f52fb0494393d60e3bc113fff0
institution DOAJ
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d72e23f52fb0494393d60e3bc113fff02025-08-20T03:11:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7448610.1371/journal.pone.0074486A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.Boyd C P GhoshRoger H S CarpenterJames B Rowe<h4>Objective</h4>We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the progression of pathophysiology.<h4>Methods</h4>Twenty three patients with progressive supranuclear palsy (Richardson's syndrome) were compared to 22 matched controls at baseline and 16 of these patients compared at baseline and one year using: the progressive supranuclear palsy rating scale; the unified Parkinson's disease rating scale; the revised Addenbrooke's cognitive examination; the frontal assessment battery; the cubes section of the visual object and space perception battery; the Hayling and Brixton executive tests; and saccadic latencies.<h4>Results</h4>Patients were significantly impaired in all domains at baseline. However, cognitive performance was maintained over a year on the majority of tests. The unified Parkinson's disease rating scale, saccadic latency and progressive supranuclear palsy rating scale deteriorated over a year, with the latter showing the largest change. Power estimates indicate that using the progressive supranuclear palsy rating scale as an outcome measure in a clinical trial would require 45 patients per arm, to identify a 50% reduction in rate of decline with 80% power.<h4>Conclusions</h4>Motor, oculomotor and cognitive domains deteriorate at different rates in progressive supranuclear palsy. This may be due to differential degeneration of their respective cortical-subcortical circuits, and has major implications for the selection of outcome measures in clinical trials due to wide variation in sensitivity to annual rates of decline.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0074486&type=printable
spellingShingle Boyd C P Ghosh
Roger H S Carpenter
James B Rowe
A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
PLoS ONE
title A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
title_full A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
title_fullStr A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
title_full_unstemmed A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
title_short A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
title_sort longitudinal study of motor oculomotor and cognitive function in progressive supranuclear palsy
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0074486&type=printable
work_keys_str_mv AT boydcpghosh alongitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy
AT rogerhscarpenter alongitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy
AT jamesbrowe alongitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy
AT boydcpghosh longitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy
AT rogerhscarpenter longitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy
AT jamesbrowe longitudinalstudyofmotoroculomotorandcognitivefunctioninprogressivesupranuclearpalsy